Targeted anticancer therapy: overexpressed receptors and nanotechnology.

scientific article published on 15 May 2014

Targeted anticancer therapy: overexpressed receptors and nanotechnology. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.CCA.2014.05.004
P698PubMed publication ID24836529
P5875ResearchGate publication ID262423277

P50authorHisham A. AlhadlaqQ39065576
Maqusood AhamedQ39065595
Mohd Javed AkhtarQ57329520
Salman A AlrokayanQ60776932
P2093author name stringSudhir Kumar
P2860cites workStructural basis for molecular recognition of folic acid by folate receptorsQ24307935
Systematic variation in gene expression patterns in human cancer cell linesQ28145747
Molecular classification of cutaneous malignant melanoma by gene expression profilingQ29619204
P921main subjectnanotechnologyQ11468
overexpressionQ61643320
P304page(s)78-92
P577publication date2014-05-15
P1433published inClinica Chimica ActaQ5133740
P1476titleTargeted anticancer therapy: overexpressed receptors and nanotechnology
P478volume436

Reverse relations

cites work (P2860)
Q92326331Actively Targeted and Redox Responsive Delivery of Anticancer Drug by Chitosan Nanoparticles
Q52684454Anti-HER2 scFv-Directed Extracellular Vesicle-Mediated mRNA-Based Gene Delivery Inhibits Growth of HER2-Positive Human Breast Tumor Xenografts by Prodrug Activation.
Q38966649Cisplatin-tethered gold nanospheres for multimodal chemo-radiotherapy of glioblastoma
Q47241458Dually responsive mesoporous silica nanoparticles regulated by upper critical solution temperature polymers for intracellular drug delivery
Q57809328Emerging Applications of Porphyrins and Metalloporphyrins in Biomedicine and Diagnostic Magnetic Resonance Imaging
Q64947947Encapsulation of Gold Nanorods with Porphyrins for the Potential Treatment of Cancer and Bacterial Diseases: A Critical Review.
Q64251799Extracellular Vesicles as Biological Shuttles for Targeted Therapies
Q90074800High Surface Reactivity and Biocompatibility of Y2O3 NPs in Human MCF-7 Epithelial and HT-1080 FibroBlast Cells
Q47370653Molecular photosensitisers for two-photon photodynamic therapy.
Q38250517Nanoparticulate carriers: an emerging tool for breast cancer therapy
Q40736574Post-Transcriptional Regulation of the GASC1 Oncogene with Active Tumor-Targeted siRNA-Nanoparticles
Q90632686Recent Advances in Polymeric Nanocomposites of Metal-Organic Frameworks (MOFs)
Q38557008Selective cancer-killing ability of metal-based nanoparticles: implications for cancer therapy.
Q52757903Sigma Receptor (σR) Ligands with Antiproliferative and Anticancer Activity.
Q97094559Silica-based organic-inorganic hybrid nanoparticles and nanoconjugates for improved anticancer drug delivery
Q28388753Silver nanoparticles induce degradation of the endoplasmic reticulum stress sensor activating transcription factor-6 leading to activation of the NLRP-3 inflammasome
Q89597205Synthesis of New Cisplatin Derivatives from Bile Acids
Q100503963Targeted delivery of 5-fluorouracil-1-acetic acid (5-FA) to cancer cells overexpressing epithelial growth factor receptor (EGFR) using virus-like nanoparticles
Q39019352Targeting Nanocarriers with Anisamide: Fact or Artifact?
Q26795601The TWEAK receptor Fn14 is a potential cell surface portal for targeted delivery of glioblastoma therapeutics
Q39177093Towards understanding the distribution and tumor targeting of sericin regulated spherical calcium phosphate nanoparticles
Q38648996Transferrin-functionalized nanographene oxide for delivery of platinum complexes to enhance cancer-cell selectivity and apoptosis-inducing efficacy
Q57469301Utilisation of Targeted Nanoparticle Photosensitiser Drug Delivery Systems for the Enhancement of Photodynamic Therapy
Q38828904Which one performs better for targeted lung cancer combination therapy: pre- or post-bombesin-decorated nanostructured lipid carriers?

Search more.